The stock of Sesen Bio Inc. (NASDAQ:SESN) decreased by decreased by -$0.1 on Friday to finish at $1.15, down -8.00 percent. The last five days have seen an average of 68,611,734 shares of common stock traded. 25 times new highs were reached in the current year, with a fall of -$0.2000. The average number of shares traded over the last 20 days was 25,302,605, while the average volume over the last 50 days totaled 31,088,676.
SESN stock appreciated 29.83% since last month. On 10/06/21, the company’s shares reached a one-month low of $0.7280. The stock touched a high of $6.04 on 08/13/21, after rallying from a low of $0.70 in 52 weeks. The price of SESN stock has declined by -14.81% or -$0.2000 this year, reaching a new high 25 times. Still, the stock price is down -80.96% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
The PE ratio of Sesen Bio Inc. has varied between 58.75 and 4.619 in the last five years. Beta for the stock is 0.61. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 13.76, the price-to-book (PB) ratio of 4.11.
For the three months ended June 29, Sesen Bio Inc.’s quick ratio was 9.30, while its current ratio was 9.30, indicating its ability to pay off its debt. Based on annual data, it had gross profit of $32.31 million and revenue of $11.24 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. SESN’s return on assets (ROA) during the last 12 months has been -71.90%. There was a 244.80% return on investment (ROI) in the past year. ROE has averaged -68.79 in the past year for the broader industry.
According to Sesen Bio Inc.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $2.23 million, while revenues rose by 100.0% to $4.31 million. It was predicted that Sesen Bio Inc.’s quarterly earnings would be -$0.15, but it ended up being -$0.06. EBITDA was -$25.36 million for the quarter. At the end of Sesen Bio Inc.’s most recent quarter ended June 29, its liabilities totaled 191.7 million, while its total debt was $43000.0. Equity owned by shareholders amounts to $196.0 million.
Here’s a quick look at Sesen Bio Inc.’s (SESN) price momentum from a technical perspective. As of 22 October, the RSI 9-day stood at 62.40%, suggesting the stock is Neutral, with a 200.71% historical volatility rate.
The stochastic %K and %D were 66.76% and 71.47% respectively, while the average true range (ATR) was 0.1497. Based on the 14-day stochastic reading of 56.87%, the RSI (14) reading is 56.01%. On the 9-day MACD Oscillator, the stock is at 0.1859, and the 14-day reading is at 0.2908.
Sesen Bio Inc. (NASDAQ: SESN) was downgraded by H.C. Wainwright to a a Neutral rating in its latest research report. The stock was previously rated as a a Buy. Analysts have assigned Sesen Bio Inc. (SESN) an Overweight rating. SESN is a stock that is recommended for selling by 0 brokerage firms, while 2 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 1 other recommend it as a buy.
What is SESN’s price target for the next 12 months?
The current consensus forecast for the stock is between $1.50 and $8.00, with a median target price of $3.00. In analyzing these forecasts, the average price target given by analysts for Sesen Bio Inc. (SESN) is $4.17.